Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yinxingmihuan Oral Solution for Chest Pain After PCI
NCT06224582Completed
- Sponsor
- National Center for Cardiovascular Disease
- Start
- Dec 2020
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in stable angina comparing Yinxingmihuan group with Placebo group (2 arms). Primary endpoint: Seattle Angina Questionnaire Angina Frequency at 12 weeks. Started Dec 2020; status: completed.
02
Drugs
Yinxingmihuan
03
Conditions
stable angina
Beyond the preview
Go deeper on NCT06224582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06224582.